197 related articles for article (PubMed ID: 11956073)
1. Cholesterol-rich lipid rafts mediate akt-regulated survival in prostate cancer cells.
Zhuang L; Lin J; Lu ML; Solomon KR; Freeman MR
Cancer Res; 2002 Apr; 62(8):2227-31. PubMed ID: 11956073
[TBL] [Abstract][Full Text] [Related]
2. Cholesterol level of lipid raft microdomains regulates apoptotic cell death in prostate cancer cells through EGFR-mediated Akt and ERK signal transduction.
Oh HY; Lee EJ; Yoon S; Chung BH; Cho KS; Hong SJ
Prostate; 2007 Jul; 67(10):1061-9. PubMed ID: 17469127
[TBL] [Abstract][Full Text] [Related]
3. Cholesterol sensitivity of endogenous and myristoylated Akt.
Adam RM; Mukhopadhyay NK; Kim J; Di Vizio D; Cinar B; Boucher K; Solomon KR; Freeman MR
Cancer Res; 2007 Jul; 67(13):6238-46. PubMed ID: 17616681
[TBL] [Abstract][Full Text] [Related]
4. Membrane rafts segregate pro- from anti-apoptotic insulin-like growth factor-I receptor signaling in colon carcinoma cells stimulated by members of the tumor necrosis factor superfamily.
Remacle-Bonnet M; Garrouste F; Baillat G; Andre F; Marvaldi J; Pommier G
Am J Pathol; 2005 Sep; 167(3):761-73. PubMed ID: 16127155
[TBL] [Abstract][Full Text] [Related]
5. Cholesterol targeting alters lipid raft composition and cell survival in prostate cancer cells and xenografts.
Zhuang L; Kim J; Adam RM; Solomon KR; Freeman MR
J Clin Invest; 2005 Apr; 115(4):959-68. PubMed ID: 15776112
[TBL] [Abstract][Full Text] [Related]
6. Antiapoptotic signaling in LNCaP prostate cancer cells: a survival signaling pathway independent of phosphatidylinositol 3'-kinase and Akt/protein kinase B.
Carson JP; Kulik G; Weber MJ
Cancer Res; 1999 Apr; 59(7):1449-53. PubMed ID: 10197612
[TBL] [Abstract][Full Text] [Related]
7. The phosphatidylinositol 3'-kinase pathway is a dominant growth factor-activated cell survival pathway in LNCaP human prostate carcinoma cells.
Lin J; Adam RM; Santiestevan E; Freeman MR
Cancer Res; 1999 Jun; 59(12):2891-7. PubMed ID: 10383151
[TBL] [Abstract][Full Text] [Related]
8. Neutral endopeptidase inhibits neuropeptide-mediated transactivation of the insulin-like growth factor receptor-Akt cell survival pathway.
Sumitomo M; Milowsky MI; Shen R; Navarro D; Dai J; Asano T; Hayakawa M; Nanus DM
Cancer Res; 2001 Apr; 61(8):3294-8. PubMed ID: 11309283
[TBL] [Abstract][Full Text] [Related]
9. Lipid raft cholesterol and genistein inhibit the cell viability of prostate cancer cells via the partial contribution of EGFR-Akt/p70S6k pathway and down-regulation of androgen receptor.
Oh HY; Leem J; Yoon SJ; Yoon S; Hong SJ
Biochem Biophys Res Commun; 2010 Mar; 393(2):319-24. PubMed ID: 20138837
[TBL] [Abstract][Full Text] [Related]
10. mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways.
Majumder PK; Febbo PG; Bikoff R; Berger R; Xue Q; McMahon LM; Manola J; Brugarolas J; McDonnell TJ; Golub TR; Loda M; Lane HA; Sellers WR
Nat Med; 2004 Jun; 10(6):594-601. PubMed ID: 15156201
[TBL] [Abstract][Full Text] [Related]
11. Androgen receptor expression is regulated by the phosphoinositide 3-kinase/Akt pathway in normal and tumoral epithelial cells.
Manin M; Baron S; Goossens K; Beaudoin C; Jean C; Veyssiere G; Verhoeven G; Morel L
Biochem J; 2002 Sep; 366(Pt 3):729-36. PubMed ID: 11971763
[TBL] [Abstract][Full Text] [Related]
12. Involvement of MAP-kinase, PI3-kinase and EGF-receptor in the stimulatory effect of Neurotensin on DNA synthesis in PC3 cells.
Hassan S; Dobner PR; Carraway RE
Regul Pept; 2004 Aug; 120(1-3):155-66. PubMed ID: 15177934
[TBL] [Abstract][Full Text] [Related]
13. Pertussis toxin-sensitive Gi/o proteins are involved in nerve growth factor-induced pro-survival Akt signaling cascade in PC12 cells.
Wu EH; Wong YH
Cell Signal; 2005 Jul; 17(7):881-90. PubMed ID: 15763430
[TBL] [Abstract][Full Text] [Related]
14. Mutant epidermal growth factor receptor signaling down-regulates p27 through activation of the phosphatidylinositol 3-kinase/Akt pathway in glioblastomas.
Narita Y; Nagane M; Mishima K; Huang HJ; Furnari FB; Cavenee WK
Cancer Res; 2002 Nov; 62(22):6764-9. PubMed ID: 12438278
[TBL] [Abstract][Full Text] [Related]
15. Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells.
Gan Y; Shi C; Inge L; Hibner M; Balducci J; Huang Y
Oncogene; 2010 Sep; 29(35):4947-58. PubMed ID: 20562913
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of nuclear factor kappaB activation in PC3 cells by genistein is mediated via Akt signaling pathway.
Li Y; Sarkar FH
Clin Cancer Res; 2002 Jul; 8(7):2369-77. PubMed ID: 12114442
[TBL] [Abstract][Full Text] [Related]
17. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
[TBL] [Abstract][Full Text] [Related]
18. PI3K-FRAP/mTOR pathway is critical for hepatocyte proliferation whereas MEK/ERK supports both proliferation and survival.
Coutant A; Rescan C; Gilot D; Loyer P; Guguen-Guillouzo C; Baffet G
Hepatology; 2002 Nov; 36(5):1079-88. PubMed ID: 12395317
[TBL] [Abstract][Full Text] [Related]
19. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.
Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ
Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705
[TBL] [Abstract][Full Text] [Related]
20. EGF-dependent cell cycle progression is controlled by density-dependent regulation of Akt activation.
LeVea CM; Reeder JE; Mooney RA
Exp Cell Res; 2004 Jul; 297(1):272-84. PubMed ID: 15194442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
